BusinessEndonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease PatientsBy Nasdaq OMXMay 1, 2018, 11:35 AM UTC
BusinessEndonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical DeviceBy Nasdaq OMXFeb 12, 2018, 2:32 PM UTC
BusinessEndonovo Therapeutics Provides Update on Acquisition of PEMF Assets, Clinical Pipeline and Pre-Clinical StudyBy Nasdaq OMXDec 28, 2017, 2:30 PM UTC
BusinessEndonovo Therapeutics Acquires Assets of Electroceuticals Developer, Rio Grande Neurosciences, and Settles LawsuitBy Nasdaq OMXDec 26, 2017, 12:30 PM UTC
